Delayed Puberty

  • Chapter
  • First Online:
Endocrinology and Diabetes

Abstract

Puberty is marked by changes in the threshold of GnRH pulse generator, and the loss of inhibition leads to pulsatile release of GnRH, which in turn stimulates the pituitary to release FSH and LH. Delayed puberty can be defined as failure to demonstrate signs of pubertal maturation by an age that is ≥2 standard deviations above the population mean. There is a wide range of conditions that can present with a delay in puberty, making a systematic tapered approach fundamental to the diagnostic process. In considering a patient with delayed puberty, the most important initial assessment is the gonadotropin status. Disorders of pubertal delay can be broadly categorized into hypogonadotropic, hypergonadotropic, and eugonadotropic hypogonadism. The failure to develop puberty in a normal and timely fashion can, therefore, cause profound anxiety in individuals and families. Furthermore, awareness that pubertal delay can indicate significant underlying pathology compels physicians to investigate any perceived deviation from a rigidly defined acceptable pattern of development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med. 2012;366(5):443–53.

    Article  CAS  PubMed  Google Scholar 

  2. Seminara SB, Crowley WF Jr. Kisspeptin and GPR54: discovery of a novel pathway in reproduction. J Neuroendocrinol. 2008;20(6):727–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lee JM, Kaciroti N, Appugliese D, Corwyn RF, Bradley RH, Lumeng JC. Body mass index and timing of pubertal initiation in boys. Arch Pediatr Adolesc Med. 2010;164(2):139–44.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nathan BM, Sedlmeyer IL, Palmert MR. Impact of body mass index on growth in boys with delayed puberty. J Pediatr Endocrinol Metab. 2006;19(8):971–7.

    Article  PubMed  Google Scholar 

  5. Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci U S A. 2005;102(5):1761–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, et al. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab. 2010;95(5):2276–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gueorguiev M, Goth ML, Korbonits M. Leptin and puberty: a review. Pituitary. 2001;4(1–2):79–86.

    Article  CAS  PubMed  Google Scholar 

  8. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341(12):879–84.

    Article  CAS  PubMed  Google Scholar 

  9. Tornberg J, Sykiotis GP, Keefe K, Plummer L, Hoang X, Hall JE, et al. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A. 2011;108(28):11524–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod. 2002;17(6):1447–52.

    Article  PubMed  Google Scholar 

  11. Xu C, Messina A, Somm E, Miraoui H, Kinnunen T, Acierno J Jr, et al. KLB, encoding beta-klotho, is mutated in patients with congenital hypogonadotropic hypogonadism. EMBO Mol Med. 2017;9(10):1379–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhu J, Choa RE, Guo MH, Plummer L, Buck C, Palmert MR, et al. A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2015;100(4):E646–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Howard SR, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr HL, et al. IGSF10 mutations dysregulate gonadotropin-releasing hormone neuronal migration resulting in delayed puberty. EMBO Mol Med. 2016;8(6):626–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003;24(5):668–93.

    Article  PubMed  Google Scholar 

  15. Delemarre EM, Felius B, Delemarre-van de Waal HA. Inducing puberty. Eur J Endocrinol. 2008;159(Suppl 1):S9–15.

    Article  CAS  PubMed  Google Scholar 

  16. Fenichel P. Delayed puberty. Endocr Dev. 2012;22:138–59.

    Article  PubMed  Google Scholar 

  17. Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87(4):1613–20.

    Article  CAS  PubMed  Google Scholar 

  18. Rosenfield RL. Clinical review 6: diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990;70(3):559–62.

    Article  CAS  PubMed  Google Scholar 

  19. Wehkalampi K, Widen E, Laine T, Palotie A, Dunkel L. Association of the timing of puberty with a chromosome 2 locus. J Clin Endocrinol Metab. 2008;93(12):4833–9.

    Article  CAS  PubMed  Google Scholar 

  20. Sedlmeyer IL, Hirschhorn JN, Palmert MR. Pedigree analysis of constitutional delay of growth and maturation: determination of familial aggregation and inheritance patterns. J Clin Endocrinol Metab. 2002;87(12):5581–6.

    Article  CAS  PubMed  Google Scholar 

  21. Albanese A, Stanhope R. Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty. J Pediatr. 1995;126(4):545–50.

    Article  CAS  PubMed  Google Scholar 

  22. Counts DR, Pescovitz OH, Barnes KM, Hench KD, Chrousos GP, Sherins RJ, et al. Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1987;64(6):1174–8.

    Article  CAS  PubMed  Google Scholar 

  23. Kelch RP, Hopwood NJ, Marshall JC. Diagnosis of gonadotropin deficiency in adolescents: limited usefulness of a standard gonadotropin-releasing hormone test in obese boys. J Pediatr. 1980;97(5):820–4.

    Article  CAS  PubMed  Google Scholar 

  24. Wu FC, Brown DC, Butler GE, Stirling HF, Kelnar CJ. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Endocrinol Metab. 1993;76(1):26–31.

    CAS  PubMed  Google Scholar 

  25. Grinspon RP, Ropelato MG, Gottlieb S, Keselman A, Martinez A, Ballerini MG, et al. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95(6):2811–8.

    Article  CAS  PubMed  Google Scholar 

  26. Resende EA, Lara BH, Reis JD, Ferreira BP, Pereira GA, Borges MF. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab. 2007;92(4):1424–9.

    Article  CAS  PubMed  Google Scholar 

  27. Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours-Nouet N, Gatelais F, Dufresne S, et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab. 2010;95(12):5225–32.

    Article  CAS  PubMed  Google Scholar 

  28. Simon D. Puberty in chronically diseased patients. Horm Res. 2002;57(Suppl 2):53–6.

    CAS  PubMed  Google Scholar 

  29. Buchacz K, Rogol AD, Lindsey JC, Wilson CM, Hughes MD, Seage GR 3rd, et al. Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr. 2003;33(1):56–65.

    Article  PubMed  Google Scholar 

  30. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, et al. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011;364(3):215–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kaplowitz P. Clinical characteristics of 104 children referred for evaluation of precocious puberty. J Clin Endocrinol Metab. 2004;89(8):3644–50.

    Article  CAS  PubMed  Google Scholar 

  32. Wyshak G, Frisch RE. Evidence for a secular trend in age of menarche. N Engl J Med. 1982;306(17):1033–5.

    Article  CAS  PubMed  Google Scholar 

  33. Semple RK, Topaloglu AK. The recent genetics of hypogonadotrophic hypogonadism – novel insights and new questions. Clin Endocrinol. 2010;72(4):427–35.

    Article  CAS  Google Scholar 

  34. Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, Hughes VA, et al. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011;96(3):E566–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wang Y, Gong C, Qin M, Liu Y, Tian Y. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism. Clin Endocrinol. 2017;87(6):757–66.

    Article  CAS  Google Scholar 

  36. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972–6.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Achermann JC, Gu WX, Kotlar TJ, Meeks JJ, Sabacan LP, Seminara SB, et al. Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. J Clin Endocrinol Metab. 1999;84(12):4497–500.

    CAS  PubMed  Google Scholar 

  38. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357(9):863–73.

    Article  CAS  PubMed  Google Scholar 

  39. Wolf NI, Vanderver A, van Spaendonk RM, Schiffmann R, Brais B, Bugiani M, et al. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology. 2014;83(21):1898–905.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Topaloglu AK, Lomniczi A, Kretzschmar D, Dissen GA, Kotan LD, McArdle CA, et al. Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome. J Clin Endocrinol Metab. 2014;99(10):E2067–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. de Vries L, Weintrob N, Phillip M. Craniopharyngioma presenting as precocious puberty and accelerated growth. Clin Pediatr (Phila). 2003;42(2):181–4.

    Article  Google Scholar 

  42. Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005;21(8–9):640–8.

    Article  PubMed  Google Scholar 

  43. Darzy KH, Shalet SM. Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Hormon IGF Res 2006;16 Suppl A:S30–40.

    Google Scholar 

  44. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet. 1998;19(2):125–33.

    Article  CAS  PubMed  Google Scholar 

  45. Reynaud R, Gueydan M, Saveanu A, Vallette-Kasic S, Enjalbert A, Brue T, et al. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J Clin Endocrinol Metab. 2006;91(9):3329–36.

    Article  CAS  PubMed  Google Scholar 

  46. Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 152A(3):674–86.

    Google Scholar 

  47. Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, et al. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab. 2005;90(10):5621–6.

    Article  CAS  PubMed  Google Scholar 

  48. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183–97.

    Article  CAS  PubMed  Google Scholar 

  49. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet. 1999;36(6):437–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian study Group for Turner's syndrome. J Clin Endocrinol Metab. 1997;82(6):1810–3.

    CAS  PubMed  Google Scholar 

  51. Latronico AC, Arnhold IJ. Inactivating mutations of LH and FSH receptors–from genotype to phenotype. Pediatr Endocrinol Rev. 2006;4(1):28–31.

    PubMed  Google Scholar 

  52. Beranova M, Oliveira LM, Bedecarrats GY, Schipani E, Vallejo M, Ammini AC, et al. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2001;86(4):1580–8.

    CAS  PubMed  Google Scholar 

  53. Layman LC. Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med. 2000;18(1):5–10.

    Article  CAS  PubMed  Google Scholar 

  54. Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KV, van Lingen BL, et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med. 1997;337(9):607–11.

    Article  CAS  PubMed  Google Scholar 

  55. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.

    Article  CAS  Google Scholar 

  56. Myhre AG, Halonen M, Eskelin P, Ekwall O, Hedstrand H, Rorsman F, et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol. 2001;54(2):211–7.

    Article  CAS  Google Scholar 

  57. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med. 1981;304(17):994–8.

    Article  CAS  PubMed  Google Scholar 

  58. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International consensus conference on intersex. Pediatrics. 2006;118(2):e488–500.

    Article  PubMed  Google Scholar 

  59. Arici A, Matalliotakis IM, Koumantakis GE, Goumenou AG, Neonaki MA, Koumantakis EE. Diagnostic role of inhibin B in resistant ovary syndrome associated with secondary amenorrhea. Fertil Steril. 2002;78(6):1324–6.

    Article  PubMed  Google Scholar 

  60. Mueller A, Berkholz A, Dittrich R, Wildt L. Spontaneous normalization of ovarian function and pregnancy in a patient with resistant ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2003;111(2):210–3.

    Article  PubMed  Google Scholar 

  61. ACOG Committee Opinion No. 355: vaginal agenesis: diagnosis, management, and routine care. Obstet Gynecol. 2006;108(6):1605–9.

    Article  Google Scholar 

  62. Wit JM, Rekers-Mombarg LT. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab. 2002;87(2):604–11.

    Article  CAS  PubMed  Google Scholar 

  63. Ibanez L, Potau N, Zampolli M, Virdis R, Gussinye M, Carrascosa A, et al. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab. 1994;78(1):30–5.

    CAS  PubMed  Google Scholar 

  64. Lanes R. A GnRH analog test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006;149(5):731; author reply –2

    Article  PubMed  Google Scholar 

  65. Wilson DA, Hofman PL, Miles HL, Unwin KE, McGrail CE, Cutfield WS. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006;148(1):89–94.

    Article  CAS  PubMed  Google Scholar 

  66. Zamboni G, Antoniazzi F, Tato L. Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys. J Pediatr. 1995;126(5 Pt 1):756–8.

    Article  CAS  PubMed  Google Scholar 

  67. Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab. 2009;94(3):780–5.

    Article  CAS  PubMed  Google Scholar 

  68. Dunkel L, Perheentupa J, Virtanen M, Maenpaa J. Gonadotropin-releasing hormone test and human chorionic gonadotropin test in the diagnosis of gonadotropin deficiency in prepubertal boys. J Pediatr. 1985;107(3):388–92.

    Article  CAS  PubMed  Google Scholar 

  69. Dunkel L, Perheentupa J, Virtanen M, Maenpaa J. GnRH and HCG tests are both necessary in differential diagnosis of male delayed puberty. Am J Dis Child. 1985;139(5):494–8.

    CAS  PubMed  Google Scholar 

  70. Degros V, Cortet-Rudelli C, Soudan B, Dewailly D. The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. Eur J Endocrinol. 2003;149(1):23–9.

    Article  CAS  PubMed  Google Scholar 

  71. Kauschansky A, Dickerman Z, Phillip M, Weintrob N, Strich D. Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Clin Endocrinol. 2002;56(5):603–7.

    Article  CAS  Google Scholar 

  72. Arrigo T, Cisternino M, Luca De F, Saggese G, Messina MF, Pasquino AM, et al. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab. 1996;9(5):511–7.

    Article  CAS  PubMed  Google Scholar 

  73. Buyukgebiz A. Treatment of constitutional delayed puberty with a combination of testosterone esters. Horm Res. 1995;44(Suppl 3):32–4.

    CAS  PubMed  Google Scholar 

  74. Soliman AT, Khadir MM, Asfour M. Testosterone treatment in adolescent boys with constitutional delay of growth and development. Metabolism. 1995;44(8):1013–5.

    Article  CAS  PubMed  Google Scholar 

  75. Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab. 2001;86(7):3039–44.

    CAS  PubMed  Google Scholar 

  76. Brook CG. Management of delayed puberty. Br Med J (Clin Res Ed). 1985;290(6469):657–8.

    Article  CAS  Google Scholar 

  77. Bondy CA. Care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab. 2007;92(1):10–25.

    Article  CAS  PubMed  Google Scholar 

  78. Achermann JC, Jameson JL. Advances in the molecular genetics of hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab. 2001;14(1):3–15.

    Article  CAS  PubMed  Google Scholar 

  79. Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet. 2001;357(9270):1743–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ambika P. Ashraf .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Colvin, C., Devineni, G., Sunil, B., Ashraf, A.P. (2022). Delayed Puberty. In: Bandeira, F., Gharib, H., Griz, L., Faria, M. (eds) Endocrinology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-90684-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-90684-9_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-90683-2

  • Online ISBN: 978-3-030-90684-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation